U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07511933) titled 'Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases' on March 30.
Brief Summary: This study aims to evaluate the diagnostic potential of 68-Gallium PSMA-PET/CT in stereotactic irradiated brain metastases from non-small cell lung cancer, melanoma and breast cancer.
Study Start Date: Dec. 24, 2019
Study Type: INTERVENTIONAL
Condition:
Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
Brain Metastases From Melanoma
Brain Metastases From Breast Cancer
Intervention:
DIAGNOSTIC_TEST: 86-Gallium PSMA PET/CT
PET/CT 45 minutes after intravenous administration of 10...